Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Diabetes Obes Metab 19(3):33647 Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH et al (2007) Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
Fill out the form to request a free attorney review.
Triple agonist or GIP/GLP-1/glucagon receptor agonist is more accurate because the compound does not act on a receptor called GLP-3
Each pen contains one weekly dose
US$ 28.26
US$ 28.88
US$ 27.73
US$ 28.91
US$ 24.02
US$ 26.55
US$ 29.50
US$ 20.23
